In patients with renal insufficiency associated with increased hemoglobin levels and polycythemia, the possibilities of recombinant erythropoietin overdosing and disorders such as neoplasms and ...

Diagnosis: Chronic renal insufficiency caused by obstructive hydronephrosis and accompanied by increased erythropoietin levels of renal origin and polycythemia. Management: Serial phlebotomies and ...

Routine administration of recombinant erythropoietin to patients on hemodialysis has greatly facilitated the management of chronic-kidney-disease-induced anemia. However, this glycoprotein hormone ...

现病史：患者10年前因胸闷就诊于急诊科，血生化示血肌酐129.7 μmol/L，尿常规大致正常，血常规示血红蛋白98 g/L。后就诊于肾内科门诊，患者无颜面及四肢水肿，尿中无泡沫增多，无尿色异常，无夜尿增多，复查血肌酐117.6 μmol/L，尿常规正常，诊断为“慢性肾功能不全”，未给予进一步治疗。

Kidney disease can occur in a person who was ... If not able to produce erythropoietin, he or she might present with low blood level (anaemia) characterised by general body weakness, headache ...

Kwality Pharmaceuticals (KPL) has secured approval from the Review Committee on Genetic Manipulation (RCGM) to commence pre-clinical toxicity studies for its recombinant Erythropoietin product, 10,000 ...

Kidneys make hormones that help control blood pressure and produce erythropoietin. It is a hormone that manages red blood ...

Kwality Pharmaceuticals rose 3.19% to Rs 895 after the company secured approval from the Review Committee on Genetic Manipulation (RCGM) to begin pre-clinical toxicity studies for the recombinant ...